Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115918) titled 'Efficacy of Pregabalin Combined with Methylcobalamin in Burning Mouth Syndrome: A Randomized Controlled Trial' on Jan. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Condition:
Burning mouth syndrome
Intervention:
Test Group:(1) Pregabalin capsules: Weeks 1-2: 75 mg per dose, twice daily
Weeks 3-4: based on participant tolerability, gradually titrate the dose up to 150 mg per dose, twice daily. Take after meals, with an interval of 12 hours between each administration.
(2) Methylcobalamin tablets: We...